Table 2. Gene expression ratios in LPS treated human PBMCs.
Gene expression ratios (Sample vs no Rx) | ||||
---|---|---|---|---|
Donor 1 | Donor 2 | |||
Gene | A Rx | B Rx | A Rx | B Rx |
C3 | 5.73 | 4.81 | 5.65 | 4.04 |
Ccl2 | 6.35 | 5.49 | 8.81 | 32.83 |
Cd14 | 6.84 | 8.08 | 2.34 | 3.93 |
Csf2 | 1.13 | 1.07 | 0.63 | 1.41 |
Cxcl8 | 28.42 | 54.41 | 8.71 | 100.50 |
Ifng | 0.66 | 0.59 | 0.84 | 54.46 |
Il1a | 27.25 | 48.70 | 7.09 | 199.61 |
Il1b | 140.28 | 288.01 | 24.40 | 838.76 |
Il6 | 38.75 | 71.99 | 2.46 | 165.05 |
Il10 | 1.37 | 3.39 | 7.05 | 49.78 |
Tnf | 2.03 | 1.91 | 1.07 | 2.05 |
Ccr5 | 0.77 | 0.49 | 0.97 | 0.41 |
Il2 | 0.28 | 0.16 | 0.80 | 0.43 |
Il4 | 0.19 | 0.27 | 2.67 | 0.87 |
Il5 | 0.06 | 0.15 | 0.82 | 0.38 |
red, overexpression compared to untreated; blue, underexpression compared to untreated; black, expression within 2-fold change.